Medicare Enrolled

Dr. Paul Rosenblit, M.D.

Endocrinology · Huntington Beach, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
18821 DELAWARE ST, Huntington Beach, CA 92648
7143755572
In practice since 2006 (19 years)
NPI: 1699862102 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rosenblit from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rosenblit? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rosenblit

Dr. Paul Rosenblit is an endocrinology specialist in Huntington Beach, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rosenblit performed 961 Medicare services across 544 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rosenblit received a total of $153,135 from 56 pharmaceutical and/or device companies across 650 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rosenblit is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 43% volume in CA $153,135 industry payments

Medicare Practice Summary

Medicare Utilization ↗
961
Medicare services
Top 43% in CA for endocrinology
544
Unique beneficiaries
$104
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~51 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
870 $99 $150
New patient office visit, complex (60-74 min) 55 $176 $325
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
20 $140 $225
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
16 $75 $125
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$153,135
Total received (2018-2024)
Avg $21,876/year across 7 years
Top 4% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
650
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$106,643 (69.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$29,735 (19.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,757 (10.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$498
2023
$3,069
2022
$6,134
2021
$12,087
2020
$31,164
2019
$35,815
2018
$64,368

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$124
Regeneron Healthcare Solutions, Inc.
$119
Novo Nordisk Inc
$82
Corcept Therapeutics
$59
Esperion Therapeutics, Inc.
$54
Boehringer Ingelheim International GmbH
$22
ABBVIE INC.
$21
AstraZeneca Pharmaceuticals LP
$17
Top 3 companies account for 65.1% of 2024 payments
All-time payments by company (2018-2024) ›
Merck Sharp & Dohme Corporation
$50,219
Amarin Pharma Inc.
$42,321
Esperion Therapeutics, Inc.
$15,412
Amgen Inc.
$12,782
Novo Nordisk Inc
$12,649
SANOFI-AVENTIS U.S. LLC
$3,892
Novo Nordisk AS
$2,130
Akcea Therapeutics, Inc.
$1,959
AstraZeneca Pharmaceuticals LP
$1,666
NOVARTIS PHARMACEUTICALS CORPORATION
$1,543
Lilly USA, LLC
$923
Regeneron Healthcare Solutions, Inc.
$906
Boehringer Ingelheim Pharmaceuticals, Inc.
$746
Novartis Pharmaceuticals Corporation
$729
Bayer Healthcare Pharmaceuticals Inc.
$649
AbbVie, Inc.
$463
Abbott Laboratories
$420
Bayer HealthCare Pharmaceuticals Inc.
$383
Horizon Therapeutics plc
$345
Corcept Therapeutics
$295
Kowa Pharmaceuticals America, Inc.
$264
Janssen Pharmaceuticals, Inc
$209
LifeScan, Inc.
$204
Becton, Dickinson and Company
$198
Medtronic MiniMed, Inc.
$180
Insulet Corporation
$166
AbbVie Inc.
$164
MannKind Corporation
$134
Janssen Scientific Affairs, LLC
$123
Shire North American Group Inc
$117
Lexicon Pharmaceuticals, Inc.
$106
Ipsen Biopharmaceuticals, Inc
$96
Mannkind Corporation
$93
SANOFI PASTEUR INC.
$72
Ultragenyx Pharmaceutical Inc.
$56
DEXCOM, INC.
$51
Medtronic, Inc.
$50
Xeris Pharmaceuticals, Inc.
$44
Regeneron Pharmaceuticals, Inc.
$42
GlaxoSmithKline, LLC.
$38
ABBVIE INC.
$38
Merck Sharp & Dohme LLC
$33
Zealand Pharma US, Inc.
$25
Boehringer Ingelheim International GmbH
$22
Bigfoot Biomedical Inc
$20
Aegerion Pharmaceuticals, Inc.
$20
Acerus Pharmaceuticals Corporation
$20
Optos, Inc.
$19
Valeritas, Inc.
$19
PFIZER INC.
$19
IBSA Pharma Inc.
$18
CeQur Corporation
$15
RECORDATI_RARE_DISEASES_INC.
$14
EUSA Pharma (US) LLC
$14
Travere Therapeutics, Inc.
$1
Retrophin, Inc.
$1
Top 3 companies account for 70.5% of all-time payments
Associated products mentioned in payments ›
(820) Cholbam · AFREZZA · Androgel · BAQSIMI · BASAGLAR · BD NANO · BD Nano · BYDUREON · CeQur Simplicity · Cholbam · DEXCOM G6 TRANSMITTER · DISEASE STATE · ENTRESTO · EVENITY · EVKEEZA · FARXIGA · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE PFS · HUMULIN · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKAMET · INVOKANA · ISTURISA · JANUVIA · JARDIANCE · JUXTAPID · Kerendia · Korlym · LEQVIO · LINZESS · Livalo · MINIMED 770G · MOUNJARO · Minimed 670G System · NATPARA · NEXLETOL · NEXLIZET · NO PRODUCT DISCUSSED · Natesto · OT Verio Flex Starter Kit · OT Verio Reflect "One Touch Meter and Strips" · Omnipod · OneTouch · OneTouch Verio Reflect · Ozempic · PANORAMIC OPHTHALMOSCOPE · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · Repatha · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · SYNTHROID · Somatuline Depot · Sylvant · Synthroid · TEGSEDI · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · Tirosint · Tresiba · UBRELVY · UNITY DIABETES MANAGEMENT SYSTEM · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · VERQUVO · Vascepa · Victoza · Wegovy · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (70%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for endocrinology in CA.

Looking for an endocrinology specialist in Huntington Beach?
Compare endocrinologists in the Huntington Beach area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
165
Per 100K population
5.2
County median income
$113,702
Nearest hospital
HUNTINGTON BEACH HOSPITAL
3.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rosenblit is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 4% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rosenblit experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rosenblit performed 870 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rosenblit receive payments from pharmaceutical companies?
Yes. Dr. Rosenblit received a total of $153,135 from 56 companies across 650 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rosenblit's costs compare to other endocrinologists in Huntington Beach?
Dr. Rosenblit's average Medicare payment per service is $104. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rosenblit) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →